Professor Mark Gillies

Professor
Clinical Ophthalmology & Eye Health, Central Clinical School

Telephone +61 2 9382 7309
Fax +61 2 9382 7318

Website Save Sight Institute
Eye Associates

Map

Research interests

Diseases of the central retina, macula

Selected grants

2015

  • The lmpact of metabolic dysfunction of Muller cells on retinal health; Du J, Gillies M; DVC Research/International Research Collaboration Award (IRCA).
  • Comparison of Müller cells isolated from the human macula and peripheral retina; Gillies M, Zhu L; Ophthalmic Research Institute of Australia (ORIA)/Research Grant.

2014

  • The development of a module for the Fight Retinal Blindness! outcome registry for diabetic retinopathy; Gillies M; Bayer Healthcare/Research Support.
  • The Eye Biobank - Establishment of Australia's first biobank for normal and diseased human eye biospecimens; Gillies M; Perpetual Trustees Charitable Trusts/Research Support.
  • The contribution of Muller cell dysfunction to retinal neuronal and vascular pathology; Gillies M; DVC Research/Bridging Support Grant.
  • The novel treatment of retinal diseases targeting at Retinol Binding Protein 3 dysregulation; Gillies M; Ophthalmic Research Institute of Australia (ORIA)/Research Grants.

2013

  • Zeiss Confocal Microscope, LSM700; McAvoy J, Martin P, Gillies M, Grunert U, Watson S, Lovicu F; DVC Research/Equipment Grant.
  • The contribution of aberrant Wnt signalling to neuronal and vascular pathology in retinal disease; Gillies M, Shen W, McAvoy J, Zhu L; National Health and Medical Research Council (NHMRC)/Project Grants.

2012

  • Glial-neuronal-vascular interactions in a novel transgenic model of Muller cell dysfunction; Gillies M, Shen W, Barnett N; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Laser treatment for Diabetic Retinopathy; Fletcher E, Wilkinson-Berka J, Gillies M, Plunkett M; National Health and Medical Research Council (NHMRC)/Development Grants.

2011

  • MACSQant Analyser (FL8); Gillies M, McCluskey P; Clive & Vera Ramaciotti Foundation/Awards for Biomedical Research: Major Equipment.
  • Practitioner Fellowship Level 1; Gillies M; National Health and Medical Research Council (NHMRC)/Career Awards: Practitioner Fellowships.
  • Role of Muller glial dysfunction in retinal diseases; Gillies M; DVC Research/Bridging Support Grant.
  • Bio-Rad CFX384 Real-Time PCR Detection System; McAvoy J, Truscott R, Gillies M, Lovicu F, Martin P, Grunert U; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2010

  • Clinical trial of intravitreal injections of dexamethasone vs bevacizumab in diabetic foveal oedema resistant to laser; Gillies M, Kaines A, Fraser-Bell S; National Health and Medical Research Council (NHMRC)/Project Grants.
  • A transgenic model for selective ablation of Müller cells in the retina; Gillies M; Ophthalmic Research Institute of Australia (ORIA)/Research Grant.
  • Ongoing prosective audit using high quality data and database linkage to improve the outcomes of macular disease; Gillies M, McAllister I, Morlet N, Keeffe J; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Regulation of bone marrow progenitor cells for diabetic retinopathy; Gillies M, Shen W; National Health and Medical Research Council (NHMRC)/Project Grants.

2009

  • Regulation of bone marrow progenitor cells for treatment of diabetic retinopathy; Shen W, Gillies M; DVC Research/Bridging Support Grant.
  • Glial-vascular dysfunction in a primate model for macular telangiectasis; Gillies M; DVC International/IPDF Grant.

2007

  • A phase IIIb, open-label, multi-centre 12 month study ... ranibizumab in patients with neovascularization secondary to age-related macular degeneration; Hanlen H, Gillies M; Novartis Pharmaceuticals Australia Pty Limited/Research Grants.
  • Proteomic analysis of a library of human vitreous samples to study abnormal protein profiles in eyes with diabetic retinopathy; Gillies M; University of Sydney/Bridging Support.
  • The Blood-Retinal Barrier - Modelling Mechanisms for Maintenance, Breakdown and Repair; King N, Madigan M, Gillies M, Provis J; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Fight Retinal Blindness; Gillies M; Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Eye Foundation/National Collaborative Project Grant.

2006

  • Proteomic analysis of a library of vitreous samples to study abnormal protein profiles in eyes with diabetic retinopathy; Gillies M; ORIA/Research Grants in Ophthalmology.
  • A natural history of macular telangiectasia; Gillies M, Heffernan C, Johns S; Lowy Medical Research Institute Ltd/Research Grants.
  • A randomised, double masked, multicenter, phase I/II study of the safety of PTK787 administered in conjuntion with photodynamic therapy with Visudyne; Gillies M, Hanlen H, Parkes S; Novotech (Australia) Pty Ltd/Research Grants.
  • An open-label extension of a randomised clinical trial of intravitreal triamcinolone for diabetic macular oedema; Gillies M, Zhu M; National Health and Medical Research Council (NHMRC)/Project Grants.

2005

  • FACS Aria for the University of Sydney Flow Cytometry Facility; King N, Pollard J, Rasko J, Lovicu F, Bishop A, Bertolino P, Briscoe H, Gillies M, Madigan M, McAvoy J, Murphy C, Balcar V, Armour C, Hughes M, Reeve V, Christopherson R, Halliday G, Christie M, Pollock C, McCaughan G, Gorrell M, Dong Q, Abendroth A, Menzies S, Barnetson R, Byrne S, Hunt N, Hambly B, Cook D, Mason R, Day M, Black J; University of Sydney/Equipment Grant.
  • Intravitreal triamcinoline (IVTA) as a treatment for diabetic macular edema; Gillies M; Diabetes Australia Research Trust/Diabetes Research Grant Program.
  • A multicentre randomised clinical trial of laser treatment plus intravitreal traimcilone for diabetic macular oedema; McAllister I, Gillies M, McAllister I, Wong T; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Treatment breakthrough of Idiopathic juxtafoveal telangietasia- Mac Tel Project: Research agreement with the Lowy Medical Research Institute Ltd.; Johns S, Gillies M; Lowy Medical Research Institute Ltd/Research Grants.

2004

  • Inverted flourescence microscope workstation, including:; McAvoy J, Lovicu F, Truscott R, Madigan M, Provis J, Gillies M, McClellan K; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Perform in-vitro (and potentially) in-vivo tests on Russian synthetic peptide for treatment of retinal eye disease; Gillies M; BioDiem Ltd/BLO Project.

2003

  • Clinical and laboratory studies of intravitreal triamcinolone for refractory diabetic macular edema; Gillies M; Juvenile Diabetes Research Foundation/Research Grant.

2002

  • HM355S rotary motorised microtome; HM340E manual rotary microtome; McAvoy J, Provis J, Gillies M, Madigan M, Lovicu F; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2000

  • The effect of retinal laser photocoagulation on the permeability of the vascular endothelium.; Gillies M; University of Sydney/University Research Grant.
  • Blood-retinal barrier permeability and tyrosine phosphorylation of junctional complexes; Gillies M; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Ophthalmic Research Institute; Gillies M; Industry Collaboration/Industry Project Support.
  • Intravitreal triamcinolone for exudative age related macula degeneration; Gillies M, Penfold P, Billson F, Simpson J; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Gillies, M. (2008). The role of intravitreal steroids in the management of diabetic retinopathy. In Elia J Duh (Eds.), Diabetic Retinopathy, (pp. 435-448). USA: Humana Press.
  • Sutter, F., Gillies, M., Helbig, H. (2007). Diabetic Macular Edema Current Treatments. In Holz F; Spaide R (Eds.), Medical Retina, (pp. 131-146). Germany: Springer.

Journals

  • Gillies, M., Walton, R., Arnold, J., McAllister, I., Simpson, J., Hunyor, A., Guymer, R., Essex, R., Morlet, N., Barthelmes, D. (2014). Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohort. Ophthalmology, 121(3), 676-681. [More Information]
  • Barthelmes, D., Zhu, L., Shen, W., Gillies, M., Irhimeh, M. (2014). Differential gene expression in Lin-/VEGF-R2+ bone marrow-derived endothelial progenitor cells isolated from diabetic mice. Cardiovascular Diabetology, 13(1), 1-10. [More Information]
  • Shen, W., Lee, S., Araujo, J., Chung, S., Zhu, L., Gillies, M. (2014). Effect of glucocorticoids on neuronal and vascular pathology in a transgenic model of selective Muller cell ablation. Glia, 62(7), 1110-1124. [More Information]
  • Gillies, M., Walton, R., Liong, J., Arnold, J., McAllister, I., Morlet, N., Hunyor, A., Guymer, R., Keeffe, J., Essex, R., Herrera-Bond, P., Glastonbury, B., Simpson, J., Barthelmes, D. (2014). Efficient capture of high-quality data on outcomes of treatment for macular diseases: The Fight Retinal Blindness! Project. Retina, 34(1), 188-195. [More Information]
  • Zhang, X., Wang, N., Schachat, A., Bao, B., Gillies, M. (2014). Glucocorticoids: Structure, Signaling and Molecular Mechanisms in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema. Current Molecular Medicine, 14(3), 376-384. [More Information]
  • Barthelmes, D., Walton, R., Arnold, J., McAllister, I., Simpson, J., Campain, A., Hunyor, A., Guymer, R., Essex, R., Morlet, N., Gillies, M. (2014). Intravitreal Therapy in Bilateral Neovascular Age-Related Macular Degeneration. Ophthalmology, 121(10), 2073-2074. [More Information]
  • Quin, G., Lyons, B., Len, A., Madigan, M., Gillies, M. (2014). Proteome changes induced by laser in diabetic retinopathy. Clinical and Experimental Ophthalmology, In Press. [More Information]
  • Tan, M., McAllister, I., Gillies, M., Verma, N., Banerjee, G., Smithies, L., Wong, W., Wong, T. (2014). Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion. American Journal of Ophthalmology, 157(1), 237-247. [More Information]
  • Shen, W., Chung, S., Irhimeh, M., Li, S., Lee, S., Gillies, M. (2014). Systemic Administration of Erythropoietin Inhibits Retinopathy in RCS Rats. PLoS One, 9(8), E104759. [More Information]
  • Finger, R., Guymer, R., Gillies, M., Keeffe, J. (2014). The Impact of Anti-Vascular Endothelial Growth Factor Treatment on Quality of Life in Neovascular Age-related Macular Degeneration. Ophthalmology, 121(6), 1246-1251. [More Information]
  • Zhu, L., Shen, W., Zhu, M., Coorey, N., Nguyen, A., Barthelmes, D., Gillies, M. (2013). Anti-Retinal Antibodies in Patients With Macular Telangiectasia Type 2. Investigative Ophthalmology and Visual Science, 54(8), 5675-5683. [More Information]
  • O'Day, R., Barthelmes, D., Zhu, M., Wong, T., McAllister, I., Arnold, J., Gillies, M. (2013). Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema. Clinical Ophthalmology (Auckland N.Z.), 7, 1565-1570. [More Information]
  • Liew, G., Quin, G., Gillies, M., Fraser-Bell, S. (2013). Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clinical and Experimental Ophthalmology, 41(2), 201-214. [More Information]
  • Barthelmes, D., Irhimeh, M., Gillies, M., Karimipour, M., Zhou, M., Zhu, L., Shen, W. (2013). Diabetes impairs mobilization of mouse bone marrow-derived Lin−/VEGF-R2+ progenitor cells. Blood Cells, Molecules and Diseases, 51(3), 163-173. [More Information]
  • Zhang, X., Wang, N., Barile, G., Bao, B., Gillies, M. (2013). Diabetic retinopathy: Neuron protection as a therapeutic target. The International Journal of Biochemistry and Cell Biology, 45(7), 1525-1529. [More Information]
  • Quin, G., Liew, G., Ho, I., Gillies, M., Fraser-Bell, S. (2013). Diagnosis and interventions for central serous chorioretinopathy: review and update. Clinical and Experimental Ophthalmology, 41(2), 187-200. [More Information]
  • Chung, S., Shen, W., Jayawardana, K., Wang, P., Yang, J., Shackel, N., Gillies, M. (2013). Differential gene expression profiling after conditional müller-cell ablation in a novel transgenic model. Investigative Ophthalmology and Visual Science, 54(3), 2142-2152. [More Information]
  • Shen, W., Zhu, L., Lee, S., Chung, S., Gillies, M. (2013). Involvement of NT3 and P75NTR in photoreceptor degeneration following selective Muller cell ablation. Journal of Neuroinflammation, 10(137), 1-13. [More Information]
  • Barthelmes, D., Irhimeh, M., Gillies, M., Zhu, L., Shen, W. (2013). Isolation and characterization of mouse bone marrow-derived Lin−/VEGF-R2+ progenitor cells. Annals of Hematology, 92(11), 1461-1472. [More Information]
  • Chung, S., Shen, W., Gillies, M. (2013). Laser Capture Microdissection-Directed Profiling of Glycolytic and mTOR Pathways in Areas of Selectively Ablated Muller Cells in the Murine Retina. Investigative Ophthalmology and Visual Science, 54(10), 6578-6584. [More Information]
  • Powner, M., Gillies, M., Zhu, M., Vevis, K., Hunyor, A., Fruttiger, M. (2013). Loss of Müller's cells and photoreceptors in macular telangiectasia type 2. Ophthalmology, 120(11), 2344-2352. [More Information]
  • Issa, P., Gillies, M., Chew, E., Bird, A., Heeren, T., Peto, T., Holz, F., Scholl, H. (2013). Macular telangiectasia type 2. Progress in Retinal and Eye Research, 34, 49-77. [More Information]
  • Clemons, T., Gillies, M., Chew, E., Bird, A., Peto, T., Wang, J., Mitchell, P., Ramdas, W., Vingerling, J. (2013). Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No. 3. Ophthalmic Epidemiology, 20(2), 109-113. [More Information]
  • Kemp, A., Preen, D., Morlet, N., CLARK, A., McAllister, I., BRIFFA, T., SANFILIPPO, F., Ng, J., MCKNIGHT, C., REYNOLDS, W., Gillies, M. (2013). Myocardial infarction after intravitreal vascular endothelial growth factor inhibitors: A whole population study. Retina, 33(5), 920-927. [More Information]
  • O'Day, R., Gillies, M., Ahlenstiel, G. (2013). Ophthalmologic complications of antiviral therapy in hepatitis C treatment. World Journal of Gastroenterology, 19(45), 8227-8237. [More Information]
  • Gillies, M., Walton, R., Simpson, J., Arnold, J., Guymer, R., McAllister, I., Hunyor, A., Essex, R., Mortlet, N., Barthelmes, D. (2013). Prospective Audit of Exudative Age-Related Macular Degeneration: 12-month Outcomes in Treatment-Naive eyes. Investigative Ophthalmology and Visual Science, 54(8), 5754-5760. [More Information]
  • Holz, F., Bandello, F., Gillies, M., Mitchell, P., Osborne, A., Sheidow, T., Souied, E., Figueroa, M. (2013). Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme. The British Journal of Ophthalmology, 97(9), 1161-1167. [More Information]
  • Zhu, M., Krilis, M., Gillies, M. (2013). The relationship between inner retinal cavitation, photoreceptor disruption, and the integrity of the outer limiting membrane in macular telangiectasia type 2. Retina, 33(8), 1547-1550. [More Information]
  • Zhang, X., Lai, D., Bao, B., Hambly, B., Gillies, M. (2013). Triamcinolone Acetonide Inhibits p38MAPK Activation and Neuronal Apoptosis in Early Diabetic Retinopathy. Current Molecular Medicine, 13(6), 946-958. [More Information]
  • Sallo, F., Peto, T., Egan, C., Wolf-Schnurrbusch, U., Clemons, T., Gillies, M., Pauleikhoff, D., Rubin, G., Chew, E., Bird, A. (2012). "En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia. Investigative Ophthalmology and Visual Science, 53(10), 6145-6152. [More Information]
  • Salem, W., Fraser-Bell, S., Gillies, M. (2012). Clinical development of new treatments for diabetic macular oedema. Clinical & Experimental Optometry, 95(3), 297-305. [More Information]
  • Shen, W., Fruttiger, M., Zhu, L., Chung, S., Barnett, N., Kirk, J., Lee, S., Coorey, N., Killingsworth, M., Sherman, L., Gillies, M. (2012). Conditional Muller Cell Ablation Causes Independent Neuronal and Vascular Pathologies in a Novel Transgenic Model. The Journal of Neuroscience, 32(45), 15715-15727. [More Information]
  • McAllister, I., Gillies, M., Smithies, L., Rochtchina, E., Harper, C., Daniell, M., Constable, I., Mitchell, P. (2012). Factors Promoting Success and Influencing Complications in Laser-Induced Central Vein Bypass. Ophthalmology, 119(12), 2579-2586. [More Information]
  • Parmalee, N., Schubert, C., Figueroa, M., Bird, A., Peto, T., Gillies, M., Bernstein, P., Kiryluk, K., Terwilliger, J., Allikmets, R. (2012). Identification of a Potential Susceptibility Locus for Macular Telangiectasia Type 2. PLoS One, 7(8), 1-10. [More Information]
  • Dabirrahmani, D., Becker, S., Hogg, M., Appleyard, R., Baroud, G., Gillies, M. (2012). Mechanical variables affecting balloon kyphoplasty outcome - a finite element study. Computer Methods in Biomechanics and Biomedical Engineering, 15(3), 211-220. [More Information]
  • Len, A., Powner, M., Zhu, L., Hageman, G., Song, X., Fruttiger, M., Gillies, M. (2012). Pilot application of iTRAQ to the retinal disease macular telangiectasia. Journal of Proteome Research, 11(2), 537-553. [More Information]
  • Jay, N., Gillies, M. (2012). Proteomic analysis of ophthalmic disease. Clinical and Experimental Ophthalmology, 40(7), 755-763. [More Information]
  • Sallo, F., Peto, T., Egan, C., Wolf-Schnurrbusch, U., Clemons, T., Gillies, M., Pauleikhoff, D., Rubin, G., Chew, E., Bird, A. (2012). The IS/OS Junction Layer in the Natural History of Type 2 Idiopathic Macular Telangiectasia. Investigative Ophthalmology and Visual Science, 53(12), 7889-7895. [More Information]
  • Coorey, N., Shen, W., Chung, S., Zhu, L., Gillies, M. (2012). The role of glia in retinal vascular disease. Clinical & Experimental Optometry, 95(3), 266-281. [More Information]
  • Zhang, X., Chen, M., Gillies, M. (2012). Two Isoforms of Flk-1 Transcripts in Early Diabetic Rat Retinas. Current Eye Research, 37(1), 73-79. [More Information]
  • Cherepanoff, S., Killingsworth, M., Zhu, M., Nolan, T., Hunyor, A., Young, S., Hageman, G., Gillies, M. (2012). Ultrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia. The British Journal of Ophthalmology, 96(11), 1404-1409. [More Information]
  • Haller, J., Bandello, F., Belfort, R., Blumenkranz, M., Gillies, M., Heier, J., Loewenstein, A., Yoon, Y., Jiao, J., Li, X., et al (2011). Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology, 118(12), 2453-2460. [More Information]
  • Becker, S., Dabirrahmani, D., Hogg, M., Appleyard, R., Baroud, G., Gillies, M. (2011). Disadvantages of balloon kyphoplasty with PMMA - A clinical and biomechanical statement. Journal fur Mineralstoffwechsel, 18(Suppl 1), 9-12.
  • Irhimeh, M., Shen, W., Chung, S., Zhu, L., Barthelmes, D., Gillies, M. (2011). Erythropoetin treatment recruits pECFCs from the marrow into the blood and stabilizes retinal vasculature. Experimental Hematology, 39(8), S77-S78.
  • Gillies, M., McAllister, I., Zhu, M., Wong, W., Louis, D., Arnold, J., Wong, T. (2011). Intravitreal Triamcinolone Prior to Laser Treatment of Diabetic Macular Edema 24-Month Results of a Randomized Controlled Trial. Ophthalmology, 118(5), 866-872. [More Information]
  • Len, A., Powner, M., Zhu, L., Hageman, G., Song, X., Fruttiger, M., Gillies, M. (2011). Pilot Application of iTRAQ to the Retinal Disease Macular Telangiectasia. Journal of Proteome Research, 11(2), 537-553. [More Information]
  • Fraser-Bell, S., Gillies, M. (2011). Retinal conditions - Part 1. Australian Doctor, 22, 27-32.
  • Fraser-Bell, S., Gillies, M. (2011). Retinal conditions - Part 2. Australian Doctor, 29, 25-32.
  • Shen, W., Zhang, J., Chung, S., Hu, Y., Ma, Z., Gillies, M. (2011). Submacular DL-alpha-Aminoadipic Acid Eradicates Primate Photoreceptors but Does Not Affect Luteal Pigment or the Retinal Vasculature. Investigative Ophthalmology and Visual Science, 52(1), 119-127. [More Information]
  • Shen, W., Li, S., Chung, S., Zhu, L., Stayt, J., Su, T., Couraud, P., Romero, I., Weksler, B., Gillies, M. (2011). Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium. European Journal of Cell Biology, 90(4), 323-332. [More Information]
  • Parmalee, N., Schubert, C., Merriam, J., Allikmets, K., Bird, A., Gillies, M., Peto, T., Figueroa, M., Friedlander, M., Fruttiger, M., et al (2010). Analysis of candidate genes for macular telangiectasia type 2. Molecular Vision, 16, 2718-2726. [More Information]
  • Szental, J., Baird, P., Richardson, A., Amirul Islam, F., Scholl, H., Issa, P., Holz, F., Gillies, M., Guymer, R. (2010). Analysis of glutathione S-transferase Pi isoform (GSTP1) single-nucleotide polymorphisms and macular telangiectasia type 2. International Ophthalmology, 30(6), 645-650. [More Information]
  • Clemons, T., Gillies, M., Chew, E., Bird, A., Peto, T., Figueroa, M., Harrington, M. (2010). Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2. Ophthalmic Epidemiology, 17(1), 66-73. [More Information]
  • Gillies, M. (2010). Bevacizumab in ophthalmology: the controversy moves forward. Clinical and Experimental Ophthalmology, 38(4), 333-334. [More Information]
  • Kuo, C., Gillies, M., McCluskey, P. (2010). Intraocular Triamcinolone for Giant Cell Arteritis? Archives of Ophthalmology, 128(12). [More Information]
  • Powner, M., Gillies, M., Tretiach, M., Scott, A., Guymer, R., Hageman, G., Fruttiger, M. (2010). Perifoveal müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology, 117(12), 2407-2416. [More Information]
  • Kuo, C., McCluskey, P., Gillies, M. (2010). Pharmacotherapeutic efficacy of preservative-free intravitreal triamcinolone acetonide. Expert Opinion on Pharmacotherapy, 11(1), 155-166. [More Information]
  • Gillies, M., McAllister, I., Zhu, M., Wong, W., Louis, D., Arnold, J., Wong, T. (2010). Pretreatment with Intravitreal Triamcinolone before Laser for Diabetic Macular Edema: 6-Month Results of a Randomised, Placebo-Controlled Trial. Investigative Ophthalmology and Visual Science, 51(5), 2322-2328. [More Information]
  • Dabirrahmani, D., Hogg, M., Kohan, L., Gillies, M. (2010). Primary and Long-Term Stability of a Short-Stem Hip Implant. Institution of Mechanical Engineers. Proceedings. Part H: Journal of Engineering in Medicine, 224(9), 1109-1119. [More Information]
  • Haller, J., Bandello, F., Belfort, R., Blumenkranz, M., Gillies, M., Heier, J., Loewenstein, A., Yoon, Y., Jacques, M., Jiao, J., et al (2010). Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology, 117(6), 1134-1146. [More Information]
  • Shen, W., Li, S., Chung, S., Gillies, M. (2010). Retinal vascular changes after glial disruption in rats. Journal of Neuroscience Research, 88(7), 1485-1499. [More Information]
  • McAllister, I., Gillies, M., Smithies, L., Rochtchina, E., Harper, C., Daniell, M., Constable, I., Mitchell, P. (2010). The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion. Ophthalmology, 117(5), 954-965. [More Information]
  • Gillies, M., Islam, F., Larsson, J., Pasadhika, S., Gaston, C., Zhu, M., Wong, T. (2010). Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial. Clinical and Experimental Ophthalmology, 38(6), 605-612. [More Information]
  • Cherepanoff, S., McMenamin, P., Gillies, M., Kettle, E., Sarks, S. (2009). Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration. The British Journal of Ophthalmology, Online(10.1136/bjo.2009.165563), 1-37. [More Information]
  • Gillies, M. (2009). Diabetic macular edema. Ophthalmology, 116(3), 595; author reply 596-7. [More Information]
  • Gillies, M., Zhu, M., Chew, E., Barthelmes, D., Hughes, E., Ali, H., Holz, F., Scholl, H., Issa, P. (2009). Familial Asymptomatic Macular Telangiectasia Type 2. Ophthalmology, 116(12), 2422-2429. [More Information]
  • Gillies, M., Simpson, J., Gaston, C., Hunt, G., Ali, H., Zhu, M., Sutter, F. (2009). Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema. Ophthalmology, 116(11), 2182-2187. [More Information]
  • Gillies, M., Simpson, J., Zhu, M., Hunt, G., Ali, H., Gaston, C. (2009). Intravitreal triamcinolone. Ophthalmology, 116(3), 591. [More Information]
  • Tikellis, G., Gillies, M., Guymer, R., McAllister, I., Shaw, J., Wong, T. (2009). Retinal vascular caliber and macular telangiectasia type 2. Ophthalmology, 116(2), 319-323. [More Information]
  • Kuo, C., Gillies, M. (2009). Role of steroids in the treatment of diabetic macular edema. International Ophthalmology Clinics, 49(2), 121-134. [More Information]
  • Zhang, X., Bao, B., Hambly, B., Gillies, M. (2009). Vascular endothelial growth factor-A: A multifunctional molecular player in diabetic retinopathy. The International Journal of Biochemistry and Cell Biology, 41(12), 2368-2371. [More Information]
  • Fischer, M., Fleischhauer, J., Gillies, M., Sutter, F., Helbig, H., Barthelmes, D. (2008). A new method to monitor visual field defects caused by photoreceptor degeneration by quantitative optical coherence tomography. Investigative Ophthalmology and Visual Science, 49(8), 3617-3621. [More Information]
  • Mitchell, P., Gillies, M., Wang, J. (2008). Author reply. Ophthalmology, 11, 214.
  • Barthelmes, D., Sutter, F., Gillies, M. (2008). Differential optical densities of intraretinal spaces. Investigative Ophthalmology and Visual Science, 49(8), 3529-3534. [More Information]
  • Liew, G., Gillies, M., Wang, J. (2008). Fenofibrate and diabetic retinopathy. The Lancet, 371(9614), 721-721. [More Information]
  • Zhang, X., Bao, B., Lai, D., Rapkins, R., Gillies, M. (2008). Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier through Differential Regulation of VEGF-A and its Receptors in Early Diabetic Rat Retinas. Diabetes, 57(4), 1026-1033. [More Information]
  • Barthelmes, D., Gillies, M., Sutter, F. (2008). Quantitative OCT analysis of idiopathic perifoveal telangiectasia. Investigative Ophthalmology and Visual Science, 49(5), 2156-2162. [More Information]
  • Larsson, J., Kifley, A., Zhu, M., Wang, J., Mitchell, P., Sutter, F., Gillies, M. (2008). Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial. Acta Ophthalmologica, doi: 10.1111/j.1755-3768.2008.01245.x, 1-6. [More Information]
  • Wickremasinghe, S., Rogers, S., Gillies, M., Zhu, M., Wong, T. (2008). Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema. Investigative Ophthalmology and Visual Science, 49(11), 4707-4711. [More Information]
  • Sliesoraityte, I., Tikellis, G., Wang, J., Mitchell, P., Gillies, M., Wong, T. (2008). Retinal vessel diameter and diabetic macular edema. Investigative Ophthalmology and Visual Science, on line(May).
  • Gillies, M. (2008). Surrogate marker. Ophthalmology, 115(2), 416-417; author reply 417. [More Information]
  • Clemons, T., Gillies, M., Chew, E., Bird, A., Peto, T., Figueroa, M., Harrington, M., MacTel Research Group, T. (2008). The National Eye Institute Visual Function Questionnaire in the macular telangiectasia (MacTel) project. Investigative Ophthalmology and Visual Science, 49(10), 4340-4346.
  • McGimpsey, S., Gillies, M. (2008). Treatment of macular degeneration--controversy and hope. The British Journal of Ophthalmology, 92(3), 436-437. [More Information]
  • Barthelmes, D., Gillies, M., Fleischhauer, J., Sutter, F. (2007). A case of idiopathic perifoveal Telangiectasia preceded by features of cone dystrophy. Eye, 21(12), 1534-1535. [More Information]
  • Gillies, M., Hogg, M., Kohan, L., Cordingley, R. (2007). Adaptive bone remodelling of all polyethylene unicompartmental tibial bearings. ANZ Journal of Surgery, 77(1- 2), 69-72. [More Information]
  • Gillies, M., Amirul Islam, F., Zhu, M., Larsson, J., Wong, T. (2007). Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema. The British Journal of Ophthalmology, 91(10), 1323-1326. [More Information]
  • Mohamed, Q., Gillies, M., Wong, T. (2007). Management of diabetic retinopathy - A systematic review. JAMA: The Journal of the American Medical Association, 298(8), 902-916. [More Information]
  • Quin, G., Len, A., Billson, F., Gillies, M. (2007). Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: New insight in the pathogenesis of diabetic retinopathy. Proteomics, 7(15), 2636-2650. [More Information]
  • Gillies, M., Wong, T. (2007). Ranibizumab for neovascular age-related macular degeneration. The New England Journal of Medicine, 356(7), 748-750. [More Information]
  • Gillies, M., Larsson, J. (2007). The effect of intravitreal triamcinolone on foveal edema in exudative macular degeneration. American Journal of Ophthalmology, 144(1), 134-136. [More Information]
  • Sirimaharaj, M., Robinson, M., Zhu, M., Csaky, K., Donovan, B., Sutter, F., Gillies, M. (2006). Intravitreal injection of triamcinolone acetonide for immune recovery uveitis. Retina: the Journal of Retinal and Vitreous Diseases, 26(5), 578-580. [More Information]
  • Gillies, M., Sutter, F., Simpson, J., Larsson, J., Ali, H., Zhu, M. (2006). Intravitreal Triamcinolone for Refractory Diabetic Macular Edema Two-Year Results of a Double-Masked, Placebo-Controlled, Randomized Clinical Trial. Ophthalmology, 113(9), 1533-1538. [More Information]
  • Chew, E., Gillies, M., Bird, A. (2006). Macular telangiectasia: a simplified classification. Archives of Ophthalmology, 124(4), 573-574. [More Information]
  • Cherepanoff, S., Mitchell, P., Wang, J., Gillies, M. (2006). Retinal autoantibody profile in early age-related macular degeneration: preliminary findings from the Blue Mountains Eye Study. Clinical and Experimental Ophthalmology, 34(6), 590-5. [More Information]
  • Gillies, M., Simpson, J., Zhu, M. (2006). Triamcinolone for occult exudative age-related macular degeneration. American Journal of Ophthalmology, 141(1), 228. [More Information]
  • Gillies, M. (2006). What we don't know about avastin might hurt us. Archives of Ophthalmology, 124(10), 1478-1479.
  • Tretiach, M., Madigan, M., Wen, L., Gillies, M. (2005). Effect of Müller cell co-culture on in vitro permeability of bovine retinal vascular endothelium in normoxic and hypoxic conditions. Neuroscience Letters, 378(3), 160-165. [More Information]
  • Gillies, M., Kuzniarz, M., Craig, J., Ball, M., Luo, W., Simpson, J. (2005). Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract. Ophthalmology, 112(1), 139-143. [More Information]
  • Wang, Y., Li, S., Zhu, M., Chen, S., Liu, Y., Men, X., Gillies, M., Larsson, J. (2005). Metamorphopsia after successful retinal detachment surgery: an optical coherence tomography study. Acta Ophthalmologica Scandinavica, 83(2), 168-171. [More Information]
  • Zhu, M., Gillies, M., Larsson, J., Sutter, F. (2005). Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. American Journal of Ophthalmology, 139(5), 802-6. [More Information]
  • Larsson, J., Gillies, M. (2005). Severe loss of vision after removal of cataract caused by intravitreal triamcinolone in combination with photodynamic therapy for exudative age-related macular degeneration. Clinical and Experimental Ophthalmology, 33(5), 544-5. [More Information]
  • Tretiach, M., Madigan, M., Gillies, M. (2004). Conditioned Medium From Mixed Retinal Pigmented Epithelium And M?Ller Cell Cultures Reduces In Vitro Permeability Of Retinal Vascular Endothelial Cells. The British Journal of Ophthalmology, 88(7), 957-961.
  • Gillies, M., Simpson, J., Sutter, F., Simpson, J. (2004). Intravitreal Triamcinolone For Diabetic Macular Edema That Persists After Laser Treatment: Three-Month Efficacy And Safety Results Of A Prospective, Randomized, Double-Masked, Placebo-Controlled Clinical Trial. Ophthalmology, 111(11), 2044-2049.
  • Gillies, M., Simpson, J., Billson, F., Luo, W., Penfold, P., Chua, W., Mitchell, P., Zhu, M., Hunyor, A. (2004). Safety Of An Intravitreal Injection Of Triamcinolone: Results From A Randomized Clinical Trial. Archives of Ophthalmology, 122(3), 336-340.
  • Gillies, M., Simpson, J., Luo, W., Penfold, P., Hunyor, A., Chua, W., Mitchell, P., Billson, F. (2003). A randomized clinical trial of a single dose of intravitreal Triamcinolone Acetonide for Neovascular age-related macular degeneration;one year results. Archives of Ophthalmology, 121, 667-673. [More Information]
  • Sutter, F., Gillies, M. (2003). Intravitreal triamcinolone for radiation-induced macular edema. Archives of Ophthalmology, 11, 1491-1492. [More Information]
  • Sutter, F., Gillies, M. (2003). Pseudo-endophthalmitis after intravitreal injection of triamcinolone. The British Journal of Ophthalmology, 87(8), 972-974.
  • Wang, J., Mitchell, P., Smith, W., Gillies, M., Billson, F. (2003). Systemic use of ani-inflammatory medications and age-related maculopathy: The Blue Mountains Eye Study. Ophthalmic Epidemiology, 10(1), 37-48.
  • van Reyk, D., Gillies, M., Davies, M. (2003). The retina: oxidative stress and diabetes. Redox Report, 8(4), 187-192.
  • Tretiach, M., Van Driel, D., Gillies, M. (2003). Transendothelial electrical resistance of bovine retinal capillary endothelial cells is influenced by cell growth patterns: an ultrastructural study. Clinical and Experimental Ophthalmology, 31(4), 348-353.
  • Penfold, P., Madigan, M., Gillies, M., Provis, J. (2001). Immunological and aetiological aspects of macular degeneration. Progress in Retinal and Eye Research, 20, 385-414.

Conferences

  • Zhu, M., Gillies, M. (2012). New insight of clinical and laboratory aspects of macular telangiectasia type 2. 17th Congress of Chinese Ophthalmological Society 2012, Nanjing, China: Chinese Ophthalmological Society.
  • Krilis, M., Zhu, M., Gillies, M. (2011). The relationship between Muller Cells and Photoreceptors in Type 2 Idiopathic Macular Telangiectasia (MacTel). 43rd Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists RANZCO 2011, Canberra, ACT, Australia.
  • Hughes, E., Zhu, M., Barthelmes, D., Ali, H., Issa, P., Gillies, M. (2008). Familial Asymptomatic Macular Telangiectasia Type 2. 40th Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists RANZCO 2008, Melbourne, VIC, Australia.
  • Zhu, M., Gillies, M., Amirul Islam, F., Larsson, J., Wong, T. (2006). Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema. AOVS Annual Meeting 2006.
  • Gillies, M., Zhu, M., Simpson, J., Sutter, F. (2005). A randomized, placebo-controlled trial of intravitreal triamcinolone acetonide for diabetic macularedema that persists or recurs after laser treatment – 2 year results. ARVO Annual Meeting 2005.
  • Zhu, M., Larsson, J., El Jamal, H., Gillies, M. (2005). Correlation between intraocular pressure, visual acuity and reduction of foveal thickness in diabetic macular oedema treated with intravitreal Triamcinolone. ARVO Annual Meeting 2005.
  • Larssor, J., Wong, J., Kifley, A., Mitchell, P., Sutter, F., Zhu, M., Gillies, M. (2005). Effect of intravitreal Triamcinolone on hard exudates in patients with diabetic retinopathy - a pilot, randomized controlled clinical trial. ARVO Annual Meeting 2005.
  • Zhu, M., Gillies, M., Kuzniarz, M., Hunyor, B., Luo, W. (2003). Safety of a second intravitreal injection of triamcinolone. Australian Ophthalmic and Visual Sciences Meeting (Melbourne 2003).

2014

  • Gillies, M., Walton, R., Arnold, J., McAllister, I., Simpson, J., Hunyor, A., Guymer, R., Essex, R., Morlet, N., Barthelmes, D. (2014). Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohort. Ophthalmology, 121(3), 676-681. [More Information]
  • Barthelmes, D., Zhu, L., Shen, W., Gillies, M., Irhimeh, M. (2014). Differential gene expression in Lin-/VEGF-R2+ bone marrow-derived endothelial progenitor cells isolated from diabetic mice. Cardiovascular Diabetology, 13(1), 1-10. [More Information]
  • Shen, W., Lee, S., Araujo, J., Chung, S., Zhu, L., Gillies, M. (2014). Effect of glucocorticoids on neuronal and vascular pathology in a transgenic model of selective Muller cell ablation. Glia, 62(7), 1110-1124. [More Information]
  • Gillies, M., Walton, R., Liong, J., Arnold, J., McAllister, I., Morlet, N., Hunyor, A., Guymer, R., Keeffe, J., Essex, R., Herrera-Bond, P., Glastonbury, B., Simpson, J., Barthelmes, D. (2014). Efficient capture of high-quality data on outcomes of treatment for macular diseases: The Fight Retinal Blindness! Project. Retina, 34(1), 188-195. [More Information]
  • Zhang, X., Wang, N., Schachat, A., Bao, B., Gillies, M. (2014). Glucocorticoids: Structure, Signaling and Molecular Mechanisms in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema. Current Molecular Medicine, 14(3), 376-384. [More Information]
  • Barthelmes, D., Walton, R., Arnold, J., McAllister, I., Simpson, J., Campain, A., Hunyor, A., Guymer, R., Essex, R., Morlet, N., Gillies, M. (2014). Intravitreal Therapy in Bilateral Neovascular Age-Related Macular Degeneration. Ophthalmology, 121(10), 2073-2074. [More Information]
  • Quin, G., Lyons, B., Len, A., Madigan, M., Gillies, M. (2014). Proteome changes induced by laser in diabetic retinopathy. Clinical and Experimental Ophthalmology, In Press. [More Information]
  • Tan, M., McAllister, I., Gillies, M., Verma, N., Banerjee, G., Smithies, L., Wong, W., Wong, T. (2014). Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion. American Journal of Ophthalmology, 157(1), 237-247. [More Information]
  • Shen, W., Chung, S., Irhimeh, M., Li, S., Lee, S., Gillies, M. (2014). Systemic Administration of Erythropoietin Inhibits Retinopathy in RCS Rats. PLoS One, 9(8), E104759. [More Information]
  • Finger, R., Guymer, R., Gillies, M., Keeffe, J. (2014). The Impact of Anti-Vascular Endothelial Growth Factor Treatment on Quality of Life in Neovascular Age-related Macular Degeneration. Ophthalmology, 121(6), 1246-1251. [More Information]

2013

  • Zhu, L., Shen, W., Zhu, M., Coorey, N., Nguyen, A., Barthelmes, D., Gillies, M. (2013). Anti-Retinal Antibodies in Patients With Macular Telangiectasia Type 2. Investigative Ophthalmology and Visual Science, 54(8), 5675-5683. [More Information]
  • O'Day, R., Barthelmes, D., Zhu, M., Wong, T., McAllister, I., Arnold, J., Gillies, M. (2013). Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema. Clinical Ophthalmology (Auckland N.Z.), 7, 1565-1570. [More Information]
  • Liew, G., Quin, G., Gillies, M., Fraser-Bell, S. (2013). Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clinical and Experimental Ophthalmology, 41(2), 201-214. [More Information]
  • Barthelmes, D., Irhimeh, M., Gillies, M., Karimipour, M., Zhou, M., Zhu, L., Shen, W. (2013). Diabetes impairs mobilization of mouse bone marrow-derived Lin−/VEGF-R2+ progenitor cells. Blood Cells, Molecules and Diseases, 51(3), 163-173. [More Information]
  • Zhang, X., Wang, N., Barile, G., Bao, B., Gillies, M. (2013). Diabetic retinopathy: Neuron protection as a therapeutic target. The International Journal of Biochemistry and Cell Biology, 45(7), 1525-1529. [More Information]
  • Quin, G., Liew, G., Ho, I., Gillies, M., Fraser-Bell, S. (2013). Diagnosis and interventions for central serous chorioretinopathy: review and update. Clinical and Experimental Ophthalmology, 41(2), 187-200. [More Information]
  • Chung, S., Shen, W., Jayawardana, K., Wang, P., Yang, J., Shackel, N., Gillies, M. (2013). Differential gene expression profiling after conditional müller-cell ablation in a novel transgenic model. Investigative Ophthalmology and Visual Science, 54(3), 2142-2152. [More Information]
  • Shen, W., Zhu, L., Lee, S., Chung, S., Gillies, M. (2013). Involvement of NT3 and P75NTR in photoreceptor degeneration following selective Muller cell ablation. Journal of Neuroinflammation, 10(137), 1-13. [More Information]
  • Barthelmes, D., Irhimeh, M., Gillies, M., Zhu, L., Shen, W. (2013). Isolation and characterization of mouse bone marrow-derived Lin−/VEGF-R2+ progenitor cells. Annals of Hematology, 92(11), 1461-1472. [More Information]
  • Chung, S., Shen, W., Gillies, M. (2013). Laser Capture Microdissection-Directed Profiling of Glycolytic and mTOR Pathways in Areas of Selectively Ablated Muller Cells in the Murine Retina. Investigative Ophthalmology and Visual Science, 54(10), 6578-6584. [More Information]
  • Powner, M., Gillies, M., Zhu, M., Vevis, K., Hunyor, A., Fruttiger, M. (2013). Loss of Müller's cells and photoreceptors in macular telangiectasia type 2. Ophthalmology, 120(11), 2344-2352. [More Information]
  • Issa, P., Gillies, M., Chew, E., Bird, A., Heeren, T., Peto, T., Holz, F., Scholl, H. (2013). Macular telangiectasia type 2. Progress in Retinal and Eye Research, 34, 49-77. [More Information]
  • Clemons, T., Gillies, M., Chew, E., Bird, A., Peto, T., Wang, J., Mitchell, P., Ramdas, W., Vingerling, J. (2013). Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No. 3. Ophthalmic Epidemiology, 20(2), 109-113. [More Information]
  • Kemp, A., Preen, D., Morlet, N., CLARK, A., McAllister, I., BRIFFA, T., SANFILIPPO, F., Ng, J., MCKNIGHT, C., REYNOLDS, W., Gillies, M. (2013). Myocardial infarction after intravitreal vascular endothelial growth factor inhibitors: A whole population study. Retina, 33(5), 920-927. [More Information]
  • O'Day, R., Gillies, M., Ahlenstiel, G. (2013). Ophthalmologic complications of antiviral therapy in hepatitis C treatment. World Journal of Gastroenterology, 19(45), 8227-8237. [More Information]
  • Gillies, M., Walton, R., Simpson, J., Arnold, J., Guymer, R., McAllister, I., Hunyor, A., Essex, R., Mortlet, N., Barthelmes, D. (2013). Prospective Audit of Exudative Age-Related Macular Degeneration: 12-month Outcomes in Treatment-Naive eyes. Investigative Ophthalmology and Visual Science, 54(8), 5754-5760. [More Information]
  • Holz, F., Bandello, F., Gillies, M., Mitchell, P., Osborne, A., Sheidow, T., Souied, E., Figueroa, M. (2013). Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme. The British Journal of Ophthalmology, 97(9), 1161-1167. [More Information]
  • Zhu, M., Krilis, M., Gillies, M. (2013). The relationship between inner retinal cavitation, photoreceptor disruption, and the integrity of the outer limiting membrane in macular telangiectasia type 2. Retina, 33(8), 1547-1550. [More Information]
  • Zhang, X., Lai, D., Bao, B., Hambly, B., Gillies, M. (2013). Triamcinolone Acetonide Inhibits p38MAPK Activation and Neuronal Apoptosis in Early Diabetic Retinopathy. Current Molecular Medicine, 13(6), 946-958. [More Information]

2012

  • Sallo, F., Peto, T., Egan, C., Wolf-Schnurrbusch, U., Clemons, T., Gillies, M., Pauleikhoff, D., Rubin, G., Chew, E., Bird, A. (2012). "En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia. Investigative Ophthalmology and Visual Science, 53(10), 6145-6152. [More Information]
  • Salem, W., Fraser-Bell, S., Gillies, M. (2012). Clinical development of new treatments for diabetic macular oedema. Clinical & Experimental Optometry, 95(3), 297-305. [More Information]
  • Shen, W., Fruttiger, M., Zhu, L., Chung, S., Barnett, N., Kirk, J., Lee, S., Coorey, N., Killingsworth, M., Sherman, L., Gillies, M. (2012). Conditional Muller Cell Ablation Causes Independent Neuronal and Vascular Pathologies in a Novel Transgenic Model. The Journal of Neuroscience, 32(45), 15715-15727. [More Information]
  • McAllister, I., Gillies, M., Smithies, L., Rochtchina, E., Harper, C., Daniell, M., Constable, I., Mitchell, P. (2012). Factors Promoting Success and Influencing Complications in Laser-Induced Central Vein Bypass. Ophthalmology, 119(12), 2579-2586. [More Information]
  • Parmalee, N., Schubert, C., Figueroa, M., Bird, A., Peto, T., Gillies, M., Bernstein, P., Kiryluk, K., Terwilliger, J., Allikmets, R. (2012). Identification of a Potential Susceptibility Locus for Macular Telangiectasia Type 2. PLoS One, 7(8), 1-10. [More Information]
  • Dabirrahmani, D., Becker, S., Hogg, M., Appleyard, R., Baroud, G., Gillies, M. (2012). Mechanical variables affecting balloon kyphoplasty outcome - a finite element study. Computer Methods in Biomechanics and Biomedical Engineering, 15(3), 211-220. [More Information]
  • Zhu, M., Gillies, M. (2012). New insight of clinical and laboratory aspects of macular telangiectasia type 2. 17th Congress of Chinese Ophthalmological Society 2012, Nanjing, China: Chinese Ophthalmological Society.
  • Len, A., Powner, M., Zhu, L., Hageman, G., Song, X., Fruttiger, M., Gillies, M. (2012). Pilot application of iTRAQ to the retinal disease macular telangiectasia. Journal of Proteome Research, 11(2), 537-553. [More Information]
  • Jay, N., Gillies, M. (2012). Proteomic analysis of ophthalmic disease. Clinical and Experimental Ophthalmology, 40(7), 755-763. [More Information]
  • Sallo, F., Peto, T., Egan, C., Wolf-Schnurrbusch, U., Clemons, T., Gillies, M., Pauleikhoff, D., Rubin, G., Chew, E., Bird, A. (2012). The IS/OS Junction Layer in the Natural History of Type 2 Idiopathic Macular Telangiectasia. Investigative Ophthalmology and Visual Science, 53(12), 7889-7895. [More Information]
  • Coorey, N., Shen, W., Chung, S., Zhu, L., Gillies, M. (2012). The role of glia in retinal vascular disease. Clinical & Experimental Optometry, 95(3), 266-281. [More Information]
  • Zhang, X., Chen, M., Gillies, M. (2012). Two Isoforms of Flk-1 Transcripts in Early Diabetic Rat Retinas. Current Eye Research, 37(1), 73-79. [More Information]
  • Cherepanoff, S., Killingsworth, M., Zhu, M., Nolan, T., Hunyor, A., Young, S., Hageman, G., Gillies, M. (2012). Ultrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia. The British Journal of Ophthalmology, 96(11), 1404-1409. [More Information]

2011

  • Haller, J., Bandello, F., Belfort, R., Blumenkranz, M., Gillies, M., Heier, J., Loewenstein, A., Yoon, Y., Jiao, J., Li, X., et al (2011). Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology, 118(12), 2453-2460. [More Information]
  • Becker, S., Dabirrahmani, D., Hogg, M., Appleyard, R., Baroud, G., Gillies, M. (2011). Disadvantages of balloon kyphoplasty with PMMA - A clinical and biomechanical statement. Journal fur Mineralstoffwechsel, 18(Suppl 1), 9-12.
  • Irhimeh, M., Shen, W., Chung, S., Zhu, L., Barthelmes, D., Gillies, M. (2011). Erythropoetin treatment recruits pECFCs from the marrow into the blood and stabilizes retinal vasculature. Experimental Hematology, 39(8), S77-S78.
  • Gillies, M., McAllister, I., Zhu, M., Wong, W., Louis, D., Arnold, J., Wong, T. (2011). Intravitreal Triamcinolone Prior to Laser Treatment of Diabetic Macular Edema 24-Month Results of a Randomized Controlled Trial. Ophthalmology, 118(5), 866-872. [More Information]
  • Len, A., Powner, M., Zhu, L., Hageman, G., Song, X., Fruttiger, M., Gillies, M. (2011). Pilot Application of iTRAQ to the Retinal Disease Macular Telangiectasia. Journal of Proteome Research, 11(2), 537-553. [More Information]
  • Fraser-Bell, S., Gillies, M. (2011). Retinal conditions - Part 1. Australian Doctor, 22, 27-32.
  • Fraser-Bell, S., Gillies, M. (2011). Retinal conditions - Part 2. Australian Doctor, 29, 25-32.
  • Shen, W., Zhang, J., Chung, S., Hu, Y., Ma, Z., Gillies, M. (2011). Submacular DL-alpha-Aminoadipic Acid Eradicates Primate Photoreceptors but Does Not Affect Luteal Pigment or the Retinal Vasculature. Investigative Ophthalmology and Visual Science, 52(1), 119-127. [More Information]
  • Krilis, M., Zhu, M., Gillies, M. (2011). The relationship between Muller Cells and Photoreceptors in Type 2 Idiopathic Macular Telangiectasia (MacTel). 43rd Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists RANZCO 2011, Canberra, ACT, Australia.
  • Shen, W., Li, S., Chung, S., Zhu, L., Stayt, J., Su, T., Couraud, P., Romero, I., Weksler, B., Gillies, M. (2011). Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium. European Journal of Cell Biology, 90(4), 323-332. [More Information]

2010

  • Parmalee, N., Schubert, C., Merriam, J., Allikmets, K., Bird, A., Gillies, M., Peto, T., Figueroa, M., Friedlander, M., Fruttiger, M., et al (2010). Analysis of candidate genes for macular telangiectasia type 2. Molecular Vision, 16, 2718-2726. [More Information]
  • Szental, J., Baird, P., Richardson, A., Amirul Islam, F., Scholl, H., Issa, P., Holz, F., Gillies, M., Guymer, R. (2010). Analysis of glutathione S-transferase Pi isoform (GSTP1) single-nucleotide polymorphisms and macular telangiectasia type 2. International Ophthalmology, 30(6), 645-650. [More Information]
  • Clemons, T., Gillies, M., Chew, E., Bird, A., Peto, T., Figueroa, M., Harrington, M. (2010). Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2. Ophthalmic Epidemiology, 17(1), 66-73. [More Information]
  • Gillies, M. (2010). Bevacizumab in ophthalmology: the controversy moves forward. Clinical and Experimental Ophthalmology, 38(4), 333-334. [More Information]
  • Kuo, C., Gillies, M., McCluskey, P. (2010). Intraocular Triamcinolone for Giant Cell Arteritis? Archives of Ophthalmology, 128(12). [More Information]
  • Powner, M., Gillies, M., Tretiach, M., Scott, A., Guymer, R., Hageman, G., Fruttiger, M. (2010). Perifoveal müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology, 117(12), 2407-2416. [More Information]
  • Kuo, C., McCluskey, P., Gillies, M. (2010). Pharmacotherapeutic efficacy of preservative-free intravitreal triamcinolone acetonide. Expert Opinion on Pharmacotherapy, 11(1), 155-166. [More Information]
  • Gillies, M., McAllister, I., Zhu, M., Wong, W., Louis, D., Arnold, J., Wong, T. (2010). Pretreatment with Intravitreal Triamcinolone before Laser for Diabetic Macular Edema: 6-Month Results of a Randomised, Placebo-Controlled Trial. Investigative Ophthalmology and Visual Science, 51(5), 2322-2328. [More Information]
  • Dabirrahmani, D., Hogg, M., Kohan, L., Gillies, M. (2010). Primary and Long-Term Stability of a Short-Stem Hip Implant. Institution of Mechanical Engineers. Proceedings. Part H: Journal of Engineering in Medicine, 224(9), 1109-1119. [More Information]
  • Haller, J., Bandello, F., Belfort, R., Blumenkranz, M., Gillies, M., Heier, J., Loewenstein, A., Yoon, Y., Jacques, M., Jiao, J., et al (2010). Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology, 117(6), 1134-1146. [More Information]
  • Shen, W., Li, S., Chung, S., Gillies, M. (2010). Retinal vascular changes after glial disruption in rats. Journal of Neuroscience Research, 88(7), 1485-1499. [More Information]
  • McAllister, I., Gillies, M., Smithies, L., Rochtchina, E., Harper, C., Daniell, M., Constable, I., Mitchell, P. (2010). The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion. Ophthalmology, 117(5), 954-965. [More Information]
  • Gillies, M., Islam, F., Larsson, J., Pasadhika, S., Gaston, C., Zhu, M., Wong, T. (2010). Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial. Clinical and Experimental Ophthalmology, 38(6), 605-612. [More Information]

2009

  • Cherepanoff, S., McMenamin, P., Gillies, M., Kettle, E., Sarks, S. (2009). Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration. The British Journal of Ophthalmology, Online(10.1136/bjo.2009.165563), 1-37. [More Information]
  • Gillies, M. (2009). Diabetic macular edema. Ophthalmology, 116(3), 595; author reply 596-7. [More Information]
  • Gillies, M., Zhu, M., Chew, E., Barthelmes, D., Hughes, E., Ali, H., Holz, F., Scholl, H., Issa, P. (2009). Familial Asymptomatic Macular Telangiectasia Type 2. Ophthalmology, 116(12), 2422-2429. [More Information]
  • Gillies, M., Simpson, J., Gaston, C., Hunt, G., Ali, H., Zhu, M., Sutter, F. (2009). Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema. Ophthalmology, 116(11), 2182-2187. [More Information]
  • Gillies, M., Simpson, J., Zhu, M., Hunt, G., Ali, H., Gaston, C. (2009). Intravitreal triamcinolone. Ophthalmology, 116(3), 591. [More Information]
  • Tikellis, G., Gillies, M., Guymer, R., McAllister, I., Shaw, J., Wong, T. (2009). Retinal vascular caliber and macular telangiectasia type 2. Ophthalmology, 116(2), 319-323. [More Information]
  • Kuo, C., Gillies, M. (2009). Role of steroids in the treatment of diabetic macular edema. International Ophthalmology Clinics, 49(2), 121-134. [More Information]
  • Zhang, X., Bao, B., Hambly, B., Gillies, M. (2009). Vascular endothelial growth factor-A: A multifunctional molecular player in diabetic retinopathy. The International Journal of Biochemistry and Cell Biology, 41(12), 2368-2371. [More Information]

2008

  • Fischer, M., Fleischhauer, J., Gillies, M., Sutter, F., Helbig, H., Barthelmes, D. (2008). A new method to monitor visual field defects caused by photoreceptor degeneration by quantitative optical coherence tomography. Investigative Ophthalmology and Visual Science, 49(8), 3617-3621. [More Information]
  • Mitchell, P., Gillies, M., Wang, J. (2008). Author reply. Ophthalmology, 11, 214.
  • Barthelmes, D., Sutter, F., Gillies, M. (2008). Differential optical densities of intraretinal spaces. Investigative Ophthalmology and Visual Science, 49(8), 3529-3534. [More Information]
  • Hughes, E., Zhu, M., Barthelmes, D., Ali, H., Issa, P., Gillies, M. (2008). Familial Asymptomatic Macular Telangiectasia Type 2. 40th Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists RANZCO 2008, Melbourne, VIC, Australia.
  • Liew, G., Gillies, M., Wang, J. (2008). Fenofibrate and diabetic retinopathy. The Lancet, 371(9614), 721-721. [More Information]
  • Zhang, X., Bao, B., Lai, D., Rapkins, R., Gillies, M. (2008). Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier through Differential Regulation of VEGF-A and its Receptors in Early Diabetic Rat Retinas. Diabetes, 57(4), 1026-1033. [More Information]
  • Barthelmes, D., Gillies, M., Sutter, F. (2008). Quantitative OCT analysis of idiopathic perifoveal telangiectasia. Investigative Ophthalmology and Visual Science, 49(5), 2156-2162. [More Information]
  • Larsson, J., Kifley, A., Zhu, M., Wang, J., Mitchell, P., Sutter, F., Gillies, M. (2008). Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial. Acta Ophthalmologica, doi: 10.1111/j.1755-3768.2008.01245.x, 1-6. [More Information]
  • Wickremasinghe, S., Rogers, S., Gillies, M., Zhu, M., Wong, T. (2008). Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema. Investigative Ophthalmology and Visual Science, 49(11), 4707-4711. [More Information]
  • Sliesoraityte, I., Tikellis, G., Wang, J., Mitchell, P., Gillies, M., Wong, T. (2008). Retinal vessel diameter and diabetic macular edema. Investigative Ophthalmology and Visual Science, on line(May).
  • Gillies, M. (2008). Surrogate marker. Ophthalmology, 115(2), 416-417; author reply 417. [More Information]
  • Clemons, T., Gillies, M., Chew, E., Bird, A., Peto, T., Figueroa, M., Harrington, M., MacTel Research Group, T. (2008). The National Eye Institute Visual Function Questionnaire in the macular telangiectasia (MacTel) project. Investigative Ophthalmology and Visual Science, 49(10), 4340-4346.
  • Gillies, M. (2008). The role of intravitreal steroids in the management of diabetic retinopathy. In Elia J Duh (Eds.), Diabetic Retinopathy, (pp. 435-448). USA: Humana Press.
  • McGimpsey, S., Gillies, M. (2008). Treatment of macular degeneration--controversy and hope. The British Journal of Ophthalmology, 92(3), 436-437. [More Information]

2007

  • Barthelmes, D., Gillies, M., Fleischhauer, J., Sutter, F. (2007). A case of idiopathic perifoveal Telangiectasia preceded by features of cone dystrophy. Eye, 21(12), 1534-1535. [More Information]
  • Gillies, M., Hogg, M., Kohan, L., Cordingley, R. (2007). Adaptive bone remodelling of all polyethylene unicompartmental tibial bearings. ANZ Journal of Surgery, 77(1- 2), 69-72. [More Information]
  • Sutter, F., Gillies, M., Helbig, H. (2007). Diabetic Macular Edema Current Treatments. In Holz F; Spaide R (Eds.), Medical Retina, (pp. 131-146). Germany: Springer.
  • Gillies, M., Amirul Islam, F., Zhu, M., Larsson, J., Wong, T. (2007). Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema. The British Journal of Ophthalmology, 91(10), 1323-1326. [More Information]
  • Mohamed, Q., Gillies, M., Wong, T. (2007). Management of diabetic retinopathy - A systematic review. JAMA: The Journal of the American Medical Association, 298(8), 902-916. [More Information]
  • Quin, G., Len, A., Billson, F., Gillies, M. (2007). Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: New insight in the pathogenesis of diabetic retinopathy. Proteomics, 7(15), 2636-2650. [More Information]
  • Gillies, M., Wong, T. (2007). Ranibizumab for neovascular age-related macular degeneration. The New England Journal of Medicine, 356(7), 748-750. [More Information]
  • Gillies, M., Larsson, J. (2007). The effect of intravitreal triamcinolone on foveal edema in exudative macular degeneration. American Journal of Ophthalmology, 144(1), 134-136. [More Information]

2006

  • Zhu, M., Gillies, M., Amirul Islam, F., Larsson, J., Wong, T. (2006). Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema. AOVS Annual Meeting 2006.
  • Sirimaharaj, M., Robinson, M., Zhu, M., Csaky, K., Donovan, B., Sutter, F., Gillies, M. (2006). Intravitreal injection of triamcinolone acetonide for immune recovery uveitis. Retina: the Journal of Retinal and Vitreous Diseases, 26(5), 578-580. [More Information]
  • Gillies, M., Sutter, F., Simpson, J., Larsson, J., Ali, H., Zhu, M. (2006). Intravitreal Triamcinolone for Refractory Diabetic Macular Edema Two-Year Results of a Double-Masked, Placebo-Controlled, Randomized Clinical Trial. Ophthalmology, 113(9), 1533-1538. [More Information]
  • Chew, E., Gillies, M., Bird, A. (2006). Macular telangiectasia: a simplified classification. Archives of Ophthalmology, 124(4), 573-574. [More Information]
  • Cherepanoff, S., Mitchell, P., Wang, J., Gillies, M. (2006). Retinal autoantibody profile in early age-related macular degeneration: preliminary findings from the Blue Mountains Eye Study. Clinical and Experimental Ophthalmology, 34(6), 590-5. [More Information]
  • Gillies, M., Simpson, J., Zhu, M. (2006). Triamcinolone for occult exudative age-related macular degeneration. American Journal of Ophthalmology, 141(1), 228. [More Information]
  • Gillies, M. (2006). What we don't know about avastin might hurt us. Archives of Ophthalmology, 124(10), 1478-1479.

2005

  • Gillies, M., Zhu, M., Simpson, J., Sutter, F. (2005). A randomized, placebo-controlled trial of intravitreal triamcinolone acetonide for diabetic macularedema that persists or recurs after laser treatment – 2 year results. ARVO Annual Meeting 2005.
  • Zhu, M., Larsson, J., El Jamal, H., Gillies, M. (2005). Correlation between intraocular pressure, visual acuity and reduction of foveal thickness in diabetic macular oedema treated with intravitreal Triamcinolone. ARVO Annual Meeting 2005.
  • Larssor, J., Wong, J., Kifley, A., Mitchell, P., Sutter, F., Zhu, M., Gillies, M. (2005). Effect of intravitreal Triamcinolone on hard exudates in patients with diabetic retinopathy - a pilot, randomized controlled clinical trial. ARVO Annual Meeting 2005.
  • Tretiach, M., Madigan, M., Wen, L., Gillies, M. (2005). Effect of Müller cell co-culture on in vitro permeability of bovine retinal vascular endothelium in normoxic and hypoxic conditions. Neuroscience Letters, 378(3), 160-165. [More Information]
  • Gillies, M., Kuzniarz, M., Craig, J., Ball, M., Luo, W., Simpson, J. (2005). Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract. Ophthalmology, 112(1), 139-143. [More Information]
  • Wang, Y., Li, S., Zhu, M., Chen, S., Liu, Y., Men, X., Gillies, M., Larsson, J. (2005). Metamorphopsia after successful retinal detachment surgery: an optical coherence tomography study. Acta Ophthalmologica Scandinavica, 83(2), 168-171. [More Information]
  • Zhu, M., Gillies, M., Larsson, J., Sutter, F. (2005). Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. American Journal of Ophthalmology, 139(5), 802-6. [More Information]
  • Larsson, J., Gillies, M. (2005). Severe loss of vision after removal of cataract caused by intravitreal triamcinolone in combination with photodynamic therapy for exudative age-related macular degeneration. Clinical and Experimental Ophthalmology, 33(5), 544-5. [More Information]

2004

  • Tretiach, M., Madigan, M., Gillies, M. (2004). Conditioned Medium From Mixed Retinal Pigmented Epithelium And M?Ller Cell Cultures Reduces In Vitro Permeability Of Retinal Vascular Endothelial Cells. The British Journal of Ophthalmology, 88(7), 957-961.
  • Gillies, M., Simpson, J., Sutter, F., Simpson, J. (2004). Intravitreal Triamcinolone For Diabetic Macular Edema That Persists After Laser Treatment: Three-Month Efficacy And Safety Results Of A Prospective, Randomized, Double-Masked, Placebo-Controlled Clinical Trial. Ophthalmology, 111(11), 2044-2049.
  • Gillies, M., Simpson, J., Billson, F., Luo, W., Penfold, P., Chua, W., Mitchell, P., Zhu, M., Hunyor, A. (2004). Safety Of An Intravitreal Injection Of Triamcinolone: Results From A Randomized Clinical Trial. Archives of Ophthalmology, 122(3), 336-340.

2003

  • Gillies, M., Simpson, J., Luo, W., Penfold, P., Hunyor, A., Chua, W., Mitchell, P., Billson, F. (2003). A randomized clinical trial of a single dose of intravitreal Triamcinolone Acetonide for Neovascular age-related macular degeneration;one year results. Archives of Ophthalmology, 121, 667-673. [More Information]
  • Sutter, F., Gillies, M. (2003). Intravitreal triamcinolone for radiation-induced macular edema. Archives of Ophthalmology, 11, 1491-1492. [More Information]
  • Sutter, F., Gillies, M. (2003). Pseudo-endophthalmitis after intravitreal injection of triamcinolone. The British Journal of Ophthalmology, 87(8), 972-974.
  • Zhu, M., Gillies, M., Kuzniarz, M., Hunyor, B., Luo, W. (2003). Safety of a second intravitreal injection of triamcinolone. Australian Ophthalmic and Visual Sciences Meeting (Melbourne 2003).
  • Wang, J., Mitchell, P., Smith, W., Gillies, M., Billson, F. (2003). Systemic use of ani-inflammatory medications and age-related maculopathy: The Blue Mountains Eye Study. Ophthalmic Epidemiology, 10(1), 37-48.
  • van Reyk, D., Gillies, M., Davies, M. (2003). The retina: oxidative stress and diabetes. Redox Report, 8(4), 187-192.
  • Tretiach, M., Van Driel, D., Gillies, M. (2003). Transendothelial electrical resistance of bovine retinal capillary endothelial cells is influenced by cell growth patterns: an ultrastructural study. Clinical and Experimental Ophthalmology, 31(4), 348-353.

2001

  • Penfold, P., Madigan, M., Gillies, M., Provis, J. (2001). Immunological and aetiological aspects of macular degeneration. Progress in Retinal and Eye Research, 20, 385-414.

To update your profile click here. For support on your academic profile contact .